Fig 1.
Waitlisted candidates: Non-invasive stress studies (NISS), additional cardiac investigations and coronary interventions.
Table 1.
Baseline characteristics in waitlisted candidates without diabetes or cardiovascular disease (Groups 1 & 2) according to NISS status.
Fig 2.
A. Time taken for transplant waitlisting in waitlisted candidates–Group 1 (No stress test), Group 2 with normal stress test & Group 2 with abnormal stress test; Time 0 –transplant recipient evaluation clinic. B. Time taken for transplant waitlisting in waitlisted candidates–Group 3a (DM+CVD-) and Group 3b (CVD+); Time 0 –transplant recipient evaluation clinic.
Fig 3.
A. Survival free of composite endpoint in waitlisted candidates–Group 1, Group 2 with normal stress test & Group 2 with abnormal stress test; Time 0 –transplant recipient evaluation clinic. B. Survival free of composite endpoint in waitlisted candidates–Group 3a (DM+CVD-) and Group 3b (CVD+); Time 0 –transplant recipient evaluation clinic.
Fig 4.
A. Clinical outcomes in waitlisted candidates–Group 1 & 2 based on non-invasive stress study. B. Clinical outcomes in waitlisted candidates–Group 3a (DM+ CVD-) and Group 3b (CVD+).
Table 2.
Cox-proportional hazard analysis for risk of composite endpoint in waitlisted candidates in Groups 1 & 2, multi-variate analysis (including factors considered relevant / significant in univariate analyses).
Table 3.
Baseline characteristics in waitlisted candidates with diabetes or pre-existing cardiovascular disease.
Table 4.
Cox-proportional hazard analysis for risk of composite endpoint of MACE or death in waitlisted candidates in Groups 3a and 3b: Multi-variate analysis (including factors considered relevant / significant in univariate analyses).
Fig 5.
Unlisted candidates: Non-invasive stress studies, additional cardiac investigations, coronary interventions and outcomes.
Table 5.
Baseline characteristics in unlisted candidates.